BridgeBio Pharma, Inc. (BBIO) › Capital ExpendituresBridgeBio Pharma, Inc. (BBIO) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2017: $464.0K2018: $2.18M2019: $2.64M2020: $7.52M2021: $13.25M2022: $4.82M2023: $1.31M2024: $933.0K2025: $1.10M$1.10M2017Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$1.10M+17.6%2024$933.0K-28.6%2023$1.31M-72.9%2022$4.82M-63.6%2021$13.25M+76.2%2020$7.52M+185.0%2019$2.64M+21.1%2018$2.18M+369.4%2017$464.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share